By the time J and J gets done with all their recalls they should have some of the most uncontaminated stuff out there:) 
This time the recall involves Risperdal Consta, the liquid, not the pills so the recalls affect more hospitals and doctor’s offices as not one consumers keep at home.
Here’s the beauty of outsourcing here I guess you could say as another drug company by the name of Alkermes made the drug who also produces a line of their products. BD
Johnson & Johnson JNJ +0.79% recalled another product Wednesday, pulling some vials of its antipsychotic treatment Risperdal Consta after discovering mold during routine quality testing.
In recent years, the New Brunswick, N.J.,
health-products maker has issued dozens of recalls for a variety of products, costing it hundreds of millions of dollars sales and prompting close government oversight of some manufacturing plants.
In the latest case, J&J JJSF +1.19% estimates that 5,000 of the 70,000 vials made in a single lot last year remain unused in doctor's offices, community mental health centers and pharmacies and must be withdrawn. Because it is injected, Risperdal Consta is stored and given at the clinics, rather than the patients keeping and taking the drug themselves.
Risperdal Consta is one of J&J's top-selling drugs, with $1.4 billion in sales last year. It is different from Risperdal pills, which patients store and take at their homes.
The Risperdal Consta that was recalled was the 25mg dose and from lot No. 309316. It was made by another company, Alkermes Inc., ALKS -0.09% and shipped from Jan. 14 to May 20, 2013, according to J&J. An Alkermes spokeswoman directed questions to J&J.
0 comments :
Post a Comment